blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3202401

EP3202401 - PPAR-SPARING THIAZOLIDINEDIONES AND COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.08.2020
Database last updated on 26.06.2024
FormerThe patent has been granted
Status updated on  20.09.2019
FormerGrant of patent is intended
Status updated on  28.05.2019
FormerExamination is in progress
Status updated on  06.07.2018
FormerRequest for examination was made
Status updated on  09.02.2018
FormerThe application has been published
Status updated on  07.07.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Cirius Therapeutics, Inc.
161 East Michigan Avenue, 4th Floor
Kalamazoo, MI 49007 / US
[2017/33]
Former [2017/32]For all designated states
Octeta Therapeutics, LLC
161 East Michigan Avenue, 4th Floor
Kalamazoo MI 49007 / US
Inventor(s)01 / COLCA, Gerard R.
125 South Kalamazoo Mall 604
Kalamazoo MI 49007 / US
02 / KLETZIEN, Rolf F.
10264 W. Gull Lake Drive
Richland MI 49083 / US
03 / TANIS, Steven P.
1750 Oriole Ct.
Carlsbad CA 92011 / US
04 / LARSEN, Scott D.
13638 Cantaberry Ct.
South Lyon MI 48178 / US
 [2019/43]
Former [2017/32]01 / COLCA, Gerard R.
125 South Kalamazoo Mall 604
Kalamazoo MI 49007 / US
02 / KLETZIEN, Rolf F.
10264 W. Gull Lake Drive
Richaland MI 49083 / US
03 / TANIS, Steven P.
1750 Oriole Ct.
Carlsbad CA 92011 / US
04 / LARSEN, Scott D.
13638 Cantaberry Ct.
South Lyon MI 48178 / US
Representative(s)Cohausz & Florack
Patent- & Rechtsanwälte
Partnerschaftsgesellschaft mbB
Bleichstraße 14
40211 Düsseldorf / DE
[2017/32]
Application number, filing date16197227.815.12.2010
[2017/32]
Priority number, dateUS20090286765P15.12.2009         Original published format: US 286765 P
US20090286713P15.12.2009         Original published format: US 286713 P
[2017/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3202401
Date:09.08.2017
Language:EN
[2017/32]
Type: B1 Patent specification 
No.:EP3202401
Date:23.10.2019
Language:EN
[2019/43]
Search report(s)(Supplementary) European search report - dispatched on:EP03.07.2017
ClassificationIPC:A61K31/426, A61K31/4439, A61P3/10
[2017/32]
CPC:
A61K31/4439 (EP,KR,US); A61K31/426 (EP,KR,US); A61K31/4436 (EP,KR,US);
A61P25/00 (EP); A61P25/16 (EP); A61P25/28 (EP);
A61P3/10 (EP); A61K2121/00 (KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/11]
Former [2017/32]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:PPAR-UMGEHENDE THIAZOLIDINEDIONE UND KOMBINATIONEN ZUR BEHANDLUNG NEURODEGENERATIVER ERKRANKUNGEN[2017/32]
English:PPAR-SPARING THIAZOLIDINEDIONES AND COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES[2017/32]
French:THIAZOLIDINEDIONES PPAR-SPARING ET COMBINAISONS POUR LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES[2017/32]
Examination procedure04.11.2016Date on which the examining division has become responsible
01.02.2018Amendment by applicant (claims and/or description)
01.02.2018Examination requested  [2018/11]
06.07.2018Despatch of a communication from the examining division (Time limit: M06)
12.02.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
12.04.2019Reply to a communication from the examining division
29.05.2019Communication of intention to grant the patent
12.09.2019Fee for grant paid
12.09.2019Fee for publishing/printing paid
12.09.2019Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP10798884.2  / EP2512470
Opposition(s)24.07.2020No opposition filed within time limit [2020/40]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
12.04.2019Request for further processing filed
12.04.2019Full payment received (date of receipt of payment)
Request granted
26.04.2019Decision despatched
Fees paidRenewal fee
04.11.2016Renewal fee patent year 03
04.11.2016Renewal fee patent year 04
04.11.2016Renewal fee patent year 05
04.11.2016Renewal fee patent year 06
04.11.2016Renewal fee patent year 07
12.12.2017Renewal fee patent year 08
12.12.2018Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.12.2010
AL23.10.2019
AT23.10.2019
CY23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
MC23.10.2019
MK23.10.2019
MT23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SI23.10.2019
SK23.10.2019
SM23.10.2019
TR23.10.2019
IE15.12.2019
LU15.12.2019
BE31.12.2019
CH31.12.2019
LI31.12.2019
BG23.01.2020
GB23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
[2022/32]
Former [2022/27]HU15.12.2010
AL23.10.2019
AT23.10.2019
CY23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
MC23.10.2019
MT23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SI23.10.2019
SK23.10.2019
SM23.10.2019
TR23.10.2019
IE15.12.2019
LU15.12.2019
BE31.12.2019
CH31.12.2019
LI31.12.2019
BG23.01.2020
GB23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2021/34]HU15.12.2010
AL23.10.2019
AT23.10.2019
CY23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
MC23.10.2019
MT23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SI23.10.2019
SK23.10.2019
SM23.10.2019
IE15.12.2019
LU15.12.2019
BE31.12.2019
CH31.12.2019
LI31.12.2019
BG23.01.2020
GB23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2021/32]HU15.12.2010
AL23.10.2019
AT23.10.2019
CY23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
MC23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SI23.10.2019
SK23.10.2019
SM23.10.2019
IE15.12.2019
LU15.12.2019
BE31.12.2019
CH31.12.2019
LI31.12.2019
BG23.01.2020
GB23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2021/26]AL23.10.2019
AT23.10.2019
CY23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
MC23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SI23.10.2019
SK23.10.2019
SM23.10.2019
IE15.12.2019
LU15.12.2019
BE31.12.2019
CH31.12.2019
LI31.12.2019
BG23.01.2020
GB23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2020/51]AL23.10.2019
AT23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
MC23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SI23.10.2019
SK23.10.2019
SM23.10.2019
IE15.12.2019
LU15.12.2019
BE31.12.2019
CH31.12.2019
LI31.12.2019
BG23.01.2020
GB23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2020/48]AL23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
MC23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SK23.10.2019
SM23.10.2019
IE15.12.2019
LU15.12.2019
BG23.01.2020
GB23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2020/46]AL23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
MC23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SK23.10.2019
SM23.10.2019
IE15.12.2019
LU15.12.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2020/39]AL23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
MC23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SK23.10.2019
SM23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2020/38]AL23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
IT23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SK23.10.2019
SM23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2020/37]AL23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
SK23.10.2019
SM23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2020/36]AL23.10.2019
CZ23.10.2019
DK23.10.2019
EE23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS23.02.2020
PT24.02.2020
Former [2020/35]AL23.10.2019
CZ23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
RO23.10.2019
RS23.10.2019
SE23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS24.02.2020
PT24.02.2020
Former [2020/34]AL23.10.2019
ES23.10.2019
FI23.10.2019
HR23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
RS23.10.2019
SE23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS24.02.2020
PT24.02.2020
Former [2020/32]AL23.10.2019
FI23.10.2019
HR23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
RS23.10.2019
SE23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS24.02.2020
PT24.02.2020
Former [2020/25]FI23.10.2019
HR23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
RS23.10.2019
SE23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS24.02.2020
PT24.02.2020
Former [2020/24]FI23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
SE23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
IS24.02.2020
PT24.02.2020
Former [2020/23]FI23.10.2019
LT23.10.2019
LV23.10.2019
NL23.10.2019
PL23.10.2019
SE23.10.2019
BG23.01.2020
NO23.01.2020
GR24.01.2020
PT24.02.2020
Former [2020/22]FI23.10.2019
LT23.10.2019
NL23.10.2019
SE23.10.2019
BG23.01.2020
NO23.01.2020
PT24.02.2020
Former [2020/21]NL23.10.2019
NO23.01.2020
Former [2020/20]NL23.10.2019
Documents cited:Search[A]WO2007109024  (METABOLIC SOLUTIONS DEV COMPAN [US], et al) [A] 1 * claims 1,2,21 * * paragraph [0162] * * paragraph [0135] *;
 [A]WO2009038681  (METABOLIC SOLUTIONS DEV COMPAN [US], et al) [A] 1 * abstract * * paragraph [0002] * * paragraph [0007] - paragraph [0008] * * paragraph [0012] * * paragraph [0014] *;
 [L]WO2010105048  (METABOLIC SOLUTIONS DEV COMPAN [US], et al) [L] * paragraph [0002] * * paragraph [0008] * * paragraph [0091] - paragraph [0137] ** claims 1-172 *;
 [A]  - GELDMACHER D S ET AL, "P1-397 Pioglitazone in Alzheimer's disease: rationale and clinical trial design", NEUROBIOLOGY OF A, TARRYTOWN, NY, US, (20040701), vol. 25, doi:10.1016/S0197-4580(04)80709-7, ISSN 0197-4580, pages S211 - S212, XP004625323 [A] 1 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0197-4580(04)80709-7
by applicantUS5304121
 US5886026
 US6099562
    - Handbook of Chemistry and Physics
    - FREIREICH ET AL., CANCER CHEMOTHER. REP., (1966), vol. 50, page 219
    - "Scientific Tables", Geigy Pharmaceuticals, ARDSLEY, (1970), vol. 537
    - J. PHARMACEUTICAL SCIENCES, (1977), vol. 66, pages 1 - 19
    - MATSUSUE K; HALUZIK M; LAMBERTG; YIM S-H; OKSANA GAVRILOVA O; WARD JM; BREWER B; REITMAN ML; GONZALEZ FJ, "Liver-specific disruption of PPAR in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes", J. CLIN. INVEST., (2003), vol. 111, page 737
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.